New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2013
10:02 EDTSMF, ROSE, UNH, GNC, FFIV, DLLR, EHTH, UPL, DVA, EBAY, CRFN, UAM, HBI, AZNOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AstraZeneca (AZN) upgraded to Neutral from Underweight at JPMorgan... DaVita (DVA) upgraded to Buy from Hold at Deutsche Bank... GNC Holdings (GNC) upgraded to Buy from Hold at Deutsche Bank... Hanesbrands (HBI) upgraded to Overweight from Equal Weight at Barclays... Qualcomm (QCOM) upgraded to Strong Buy from Outperform at Raymond James... Ultra Petroleum (UPL) upgraded to Buy from Hold at Brean Capital... UnitedHealth (UNH) upgraded to Strong Buy from Outperform at Raymond James... Universal American (UAM) upgraded to Market Perform from Underperform at Raymond James... eHealth (EHTH) upgraded to Buy from Neutral at Janney Capital... Rosetta Resources (ROSE) upgraded to Focus List from Sector Perform at Howard Weil... Qualcomm (QCOM) upgraded at Raymond James... Crescent Financial (CRFN) upgraded to Outperform from Market Perform at Raymond Jamesl... DFC Global (DLLR) upgraded to Buy from Neutral at Nomura... Salient MLP & Energy Infrastructure (SMF) upgraded to Buy from Hold at Stifel... eBay (EBAY) upgraded to Buy from Hold at Topeka... F5 Networks (FFIV) upgraded to Outperform from Neutral at RW Baird.
News For AZN;DVA;GNC;HBI;UPL;UNH;UAM;EHTH;ROSE;CRFN;DLLR;SMF;EBAY;FFIV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 17, 2014
07:07 EDTAZNMedImmune presents new data in systemic lupus
Subscribe for More Information
06:48 EDTFFIVState Department hacked, NY Times reports
Subscribe for More Information
06:43 EDTAZNAstraZeneca, Pfizer deal seen less likely after Merck transaction, Reuters says
Subscribe for More Information
November 16, 2014
14:08 EDTDVADaVita announces collaboration with Medtronic
DaVita Kidney Care, a division of DaVita HealthCare Partners (DVA) and leading provider of kidney care services, announced a collaboration with Medtronic (MDT) to better understand cardiovascular health in end stage renal disease, ESRD patients. The collaboration will focus on developing a pilot program using Medtronic's Reveal LINQ Insertable Cardiac Monitoring system to identify cardiac arrhythmias in patients receiving dialysis. "Medtronic recently announced data at the American Society of Nephrology meeting that showed a higher incidence of arrhythmias in patients receiving hemodialysis," said Ven Manda, vice president, Renal Care Solutions at Medtronic. "We are pleased to pursue this collaboration with DaVita to monitor more patients and gather additional data that will further our understanding of the relationship between dialysis and cardiac events in ESRD patients." "Given the high incidence rate of cardiovascular disease and events in ESRD patients, we believe that by collaborating with Medtronic, we can gain knowledge to help improve the lives of ESRD patients," said Mahesh Krishnan, vice president for clinical innovation and public policy for DaVita HealthCare Partners. "Through the collaboration we expect to utilize innovative monitoring technology and data from our DaVita Kidney Care information systems across the country. This effort is poised to improve the lives of patients by proactively detecting and preventing cardiac complications."
13:36 EDTAZNAstraZeneca presents data from studies of lesinurad combined with allopurinol
Subscribe for More Information
November 14, 2014
17:01 EDTEBAYIcahn Associates gives quarterly update on stakes
Subscribe for More Information
16:58 EDTEBAYThird Point gives quarterly update on stakes
NEW STAKES: Alibaba (BABA), eBay (EBAY), Bed Bath & Beyond (BBBY), Shire (SHPG), and Parker Hannifin (PH). INCREASED STAKES: Actavis (ACT), Amgen (AMGN), EQT (EQT), Sensata (ST), Coca-Cola Enterprises (CCE). DECREASED STAKES: Williams Cos (WMB), Ally Financial (ALLY), Cheniere Energy (LNG), YPF (YPF), and FedEx (FDX). LIQUIDATED STAKES: AIG (AIG), T-Mobile (TMUS), Rackspace (RAX), Hertz (HTZ), and Citrix Systems (CTXS).
14:53 EDTAZNCVS Express Scripts implementing drug price controls, says Cleveland Research
Cleveland Research believes that CVS (CVS) and Express scripts are implementing rebates and price controls on drug. The firm expects the companies to increase their focus on controlling durg prices next year, and adds that they have already itnroduced prior authorization criteria for hepatitis drug. Publicly traded drug companies include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Makers of hepatits c drugs include AbbVie (ABBV) and Gilead (GILD),
09:38 EDTEBAYJANA Partners gives quarterly update on stakes
NEW STAKES: AMD (AMD), AECOM Technology (ACM), Alibaba (BABA), McDonald's (MCD), Amgen (AMGN), Gaming and Leisure Properties (GLPI), Iron Mountain (IRM), iRobot (IRBT), Seadrill Partners (SDLP), Valeant (VRX). INCREASED STAKES: eBay (EBAY), Charter (CHTR), Groupon (GRPN), HD Supply (HDS), Hertz (HTZ). DECREASED STAKES: Apache (APA). LIQUIDATED STAKES: CBS (CBS), Endo (ENDP), FMC Corporation (FMC), SeaWorld (SEAS), SunEdison (SUNE).
07:14 EDTAZNAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.
November 13, 2014
12:12 EDTFFIVF5 Networks sees product revenue growth throughout FY15
Subscribe for More Information
12:08 EDTFFIVF5 Networks repeats Q1 EPS view $1.46-$1.49, consensus $1.49
Subscribe for More Information
11:14 EDTFFIVF5 Networks 'positioned better than ever,' says Cantor
Subscribe for More Information
10:01 EDTROSEOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:30 EDTEBAYDiscover COO says U.S. consumer 'not great'
Subscribe for More Information
08:29 EDTROSERosetta Resources upgraded at BMO Capital
Subscribe for More Information
07:16 EDTAZNBIT Congress to hold a conference
Subscribe for More Information
07:03 EDTAZNAstraZeneca initiates development program for Brilinta reversal agent
Subscribe for More Information
05:34 EDTAZNAstraZeneca, Isis Pharmaceuticals to co-develop oligonucleotide delivery methods
Subscribe for More Information
04:10 EDTROSERosetta Resources upgraded to Outperform from Market Perform at BMO Capital
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use